N. Cheung

发表

5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma

S. Roberts, K. Kramer, S. Modak, 2013, Bone Marrow Transplantation.

N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.

W. Gerald, J. Mora, G. Heller, 2001, Medical and pediatric oncology.

Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery.

G. Heller, M. LaQuaglia, S. Wolden, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.

S. Larson, H. Yeung, B. Kushner, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma.

B. Kushner, K. Kramer, N. Cheung, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral etoposide for refractory and relapsed neuroblastoma.

B. Kushner, K. Kramer, N. Cheung, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers.

W. Gerald, M. Ladanyi, P. Ambros, 1997, European journal of cancer.

Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.

W. Gerald, M. Ladanyi, P. Ambros, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.

T. Polyak, D. Bajorin, G. Heller, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Colon and rectal carcinoma: clinical experience.

R. Hobson, N. Cheung, A. Najem, 1977, The American surgeon.

Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy.

K S Pentlow, M C Graham, R M Lambrecht, 1991, Medical physics.

Technical challenges associated with the radiolabeling of monoclonal antibodies utilizing short-lived, positron emitting radionuclides.

R. Finn, C. Divgi, K. Pentlow, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma.

B. Kushner, N. Cheung, B. Kushner, 1989, Blood.

Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: dosimetry calculations incorporating cross-organ beta doses.

L. Kostakoglu, K. Garmestani, O. Gansow, 1996, Nuclear medicine and biology.

Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.

S. Gultekin, Hong-fen Guo, K. Kramer, 2001, Cancer research.

Current status of radioimmunotherapy.

S. Larson, D. Scheinberg, A. Scott, 1994, Nuclear medicine and biology.

Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8.

J. Humm, R. Finn, K. Kramer, 2000, Medical and pediatric oncology.

Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities.

S. Larson, M. LaQuaglia, R. Finn, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.

W. Gerald, G. Heller, M. LaQuaglia, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors.

P. Meyers, B. Kushner, K. Kramer, 2000, Medical and pediatric oncology.

Optimizing the recovery of chemically reduced monoclonal antibody for site-specific technetium-99m radiolabeling.

R. Finn, N. Cheung, S. Larson, 1993, BioTechniques.

99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors.

G. Bridger, M. Abrams, R. Fonti, 1999, Nuclear medicine and biology.

Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.

W. Gerald, S. Larson, B. Kushner, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Ganglioside gd(2) expression in the human nervous-system and in neuroblastomas - an immunohistochemical study.

M. Rosenblum, G. Lammie, N. Cheung, 1993, International journal of oncology.

Reduction of interference by specific IgG with a modified microtiter solid-phase radioimmunoassay to measure honeybee venom IgE.

N. Cheung, N. Lewiston, M. Reid, 1983, The Journal of allergy and clinical immunology.

Microtiter solid-phase radioimmunoassay for specific immunoglobulin E.

N. Cheung, N. Lewiston, M. Reid, 1981, The Journal of allergy and clinical immunology.

An assessment of monocyte procoagulant activity in patients with solid tumors.

N. Cheung, C. Spillert, K. Dasmahapatra, 1987, The Journal of surgical research.

Clinically critical impact of molecular genetic studies in pediatric solid tumors.

W. Gerald, M. Ladanyi, A. Hamelin, 1999, Medical and pediatric oncology.

Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis.

W. Gerald, M. Ladanyi, M. LaQuaglia, 1999, Medical and pediatric oncology.

Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.

W. Gerald, T. Merchant, P. Steinherz, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allelic loss of chromosome 1p in neuroblastoma.

B. Kushner, N. Cheung, 1996, The New England journal of medicine.

Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.

M. LaQuaglia, B. Kushner, R. O'reilly, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system

K. Kramer, S. Modak, N. Kernan, 2006, Bone Marrow Transplantation.

International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review.

W. Gerald, M. Ladanyi, P. Ambros, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Absolute requirement of CD11/CD18 adhesion molecules, FcRII and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity.

B. Kushner, B. Kushner, N. Cheung, 1992, Blood.

Underestimation of specific immunoglobulin E by microtiter plate enzyme-linked immunosorbent assays.

R. Moss, N. Cheung, M. Reid, 1985, The Journal of allergy and clinical immunology.

Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review.

S. Jhanwar, G. Heller, B. Kushner, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Novel Tumor-Associated Surface Antigen: Broad Distribution among Neuroectodermal, Mesenchymal and Epithelial Tumors, with Restricted Expression among Normal Tissues † 785

M. Ladanyi, S. Gultekin, M. Rosenfeld, 1998, Pediatric Research.

Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.

W. Gerald, K. Kramer, N. Cheung, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Multimodality preoperative treatment for advanced cancer of the head and neck.

N. Cheung, K. Dasmahapatra, G. Hill, 1984, American journal of surgery.

Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome.

G. Heller, B. Kushner, M. Bonilla, 1994, Journal of pediatric surgery.

Honey bee venom specific immunoglobulin G4 in honey bee sting allergic patients and bee keepers.

N. Cheung, M. Reid, J. Blessing-Moore, 1983, Annals of allergy.

NCCN pediatric neuroblastoma practice guidelines. The National Comprehensive Cancer Network.

F. Hoffer, R. Shamberger, N. Kapoor, 1996, Oncology.

Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial.

E. Schiff, F. Cerra, J. Fischer, 1985, JPEN. Journal of parenteral and enteral nutrition.

Changes in plasma amino acid profiles following abdominal operations.

N. Cheung, G. Dikdan, B. Rush, 1981, Surgery, gynecology & obstetrics.

Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma.

W. Gerald, B. Kushner, K. Kramer, 2001, Medical and pediatric oncology.

Monoclonal antibody to human Trk-A: diagnostic and therapeutic potential in neuroblastoma.

W. Gerald, H. Saragovi, K. Kramer, 1997, European journal of cancer.

Clinically effective monoclonal antibody 3F8 mediates nonoxidative lysis of human neuroectodermal tumor cells by polymorphonuclear leukocytes.

B. Kushner, N. Cheung, 1991, Cancer research.

Detecting neuroblastoma using bone marrow aspiration and bone marrow biopsy.

N. Cheung, 2000, Journal of pediatric hematology/oncology.

Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma.

W. Gerald, M. LaQuaglia, H. Saragovi, 1997, European journal of cancer.

Dose-intensity analysis and randomized trials.

G. Heller, N. Cheung, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgical endoscopy training in a university program.

N. Cheung, K. Dasmahapatra, A. Najem, 1986, The American surgeon.